Second-line agent for gastroesophageal adenocarcinoma ups survivalJanuary 29, 2013GastroenterologyGastrointestinal Cancer
FDA approves bevacizumab for second-line combinationsJanuary 25, 2013GastroenterologyGastrointestinal Cancer
Resecting residual gastrointestinal stromal tumors improved survivalJanuary 24, 2013GastroenterologySarcoma & GISTGastrointestinal Cancer
Second-line docetaxel benefits seen for esophagogastric cancersJanuary 23, 2013GastroenterologyGastrointestinal Cancer
Risk of anal cancer is high in HIV-infected people January 23, 2013GastroenterologyPreventive CareGastrointestinal Cancer
Lymph node count may not be best predictor of colon cancer survivalJanuary 7, 2013GastroenterologyGastrointestinal Cancer
Ten percent of neoplastic polyps may be incompletely resectedJanuary 3, 2013GastroenterologyGastrointestinal Cancer
Poor performance seen after optical biopsy trainingJanuary 3, 2013GastroenterologyGastrointestinal Cancer
Staged surgery found unnecessary for colorectal tumorsJanuary 3, 2013GastroenterologyGastrointestinal Cancer
Rapid Feedback Boosts Adherence to Oncology Quality MeasuresDecember 4, 2012Breast CancerGastroenterologyPractice ManagementGastrointestinal Cancer
QOPI Raises Adherence to Oncology Guidelines - but Some Efforts LagNovember 30, 2012GastroenterologyPractice ManagementGastrointestinal Cancer
Psoriasis Patients Have Low Rates of Common CancersNovember 30, 2012Breast CancerGastroenterologyGenitourinary CancerGastrointestinal Cancer
Tivantinib Shows Modest Benefit in Relapsed Liver CancerNovember 26, 2012GastroenterologyRare DiseasesGastrointestinal Cancer
Brivanib Can't Match Sorafenib for Advanced Liver CancerNovember 19, 2012GastroenterologyGastrointestinal Cancer
